Corrective and Preventive Action (CAPA) is a fundamental part of an effective quality management system. For companies operating in FDA-regulated industries, CAPA provides a structured way to investigate quality problems, identify their causes, implement corrective or preventive actions, and verify that those actions are effective.
For medical device manufacturers, FDA CAPA requirements have also evolved with the introduction of the Quality Management System Regulation (QMSR). Since February 2, 2026, the QMSR has replaced the former Quality System Regulation framework under 21 CFR Part 820 and incorporates ISO 13485:2016 by reference.
This article explains the CAPA definition FDA-regulated organizations should understand, the current FDA CAPA guidance and requirements, an FDA CAPA example, and how CAPA management software for FDA regulated industries can help organizations manage the process.
What Is CAPA?
CAPA stands for Corrective and Preventive Action.
CAPA is a systematic process used to:
- Identify actual or potential quality problems
- Investigate the causes of problems
- Correct existing nonconformities
- Prevent problems from recurring
- Prevent potential problems from occurring
- Implement appropriate actions
- Verify or evaluate whether actions are effective
- Maintain appropriate quality records
In practical terms, CAPA is not simply about fixing a problem. The objective is to understand why the problem occurred and what needs to change to prevent recurrence or reduce the likelihood of a potential problem.
For FDA-regulated organizations, CAPA can be connected to information from sources such as nonconformances, complaints, audits, returned products, quality records, process data, and other quality information.
CAPA Definition FDA: What Does CAPA Mean?
Historically, FDA’s medical-device Quality System Regulation included specific CAPA requirements under 21 CFR 820.100.
The FDA’s earlier guidance described CAPA as a systematic approach involving correction, corrective action, and preventive action.
However, there is an important regulatory update for medical device manufacturers.
CAPA under the FDA QMSR
The FDA’s Quality Management System Regulation (QMSR) became effective on February 2, 2026. The QMSR incorporates ISO 13485:2016 by reference and includes corrective and preventive action requirements through ISO 13485 Clauses 8.5.2 and 8.5.3.
Under the QMSR framework:
- Corrective action addresses actual nonconformities and is intended to prevent recurrence.
- Preventive action addresses potential nonconformities and is intended to prevent occurrence.
- Actions should be appropriate to the magnitude of the problem and the risks involved.
The FDA has specifically stated that it incorporated ISO 13485 requirements for corrective and preventive action into the QMSR.
Therefore, organizations searching for “CAPA definition FDA” should be aware that older references to 21 CFR 820.100 describe the previous QS Regulation, while medical device manufacturers now need to consider the requirements of the QMSR and incorporated ISO 13485 requirements.
What Is the Purpose of CAPA for FDA-Regulated Companies?
CAPA helps organizations move from simply reacting to individual problems toward systematically improving their quality systems.
A typical CAPA process can help an organization:
1. Identify Quality Problems
Quality problems may be identified through:
- Internal audits
- External audits
- Customer complaints
- Nonconforming products
- Manufacturing deviations
- Returned products
- Inspection results
- Supplier issues
- Process monitoring
- Quality trends
- Employee reports
- Regulatory observations
The organization should have a defined process for determining when an issue requires a CAPA investigation.
2. Investigate the Problem
The investigation should establish what happened, where it happened, when it happened, and how significant the problem is.
Depending on the issue, organizations may use techniques such as:
- 5 Whys
- Fishbone/Ishikawa analysis
- Pareto analysis
- Fault tree analysis
- Failure Mode and Effects Analysis (FMEA)
- Process analysis
- Trend analysis
- Statistical analysis
The investigation should focus on identifying the root cause or contributing causes, rather than simply addressing the visible symptom.
3. Determine Appropriate Actions
Once the cause has been established, the organization determines what actions are necessary.
Corrective actions may include:
- Revising procedures
- Changing a manufacturing process
- Improving employee training
- Modifying equipment
- Improving inspection controls
- Changing supplier controls
- Updating specifications
- Revising documentation
- Implementing additional monitoring
Preventive actions may be implemented when analysis identifies a potential problem before it results in an actual nonconformity.
4. Implement the Actions
Actions should be assigned to responsible personnel with defined deadlines.
A well-managed CAPA should make it possible to answer:
Who is responsible? What needs to be done? When is it due? What evidence demonstrates completion?
5. Verify Effectiveness
Completing an action does not automatically mean that the CAPA was effective.
The organization should determine whether the action actually addressed the underlying problem.
For example, if additional employee training was implemented after repeated documentation errors, the company could monitor subsequent records to determine whether similar errors continue to occur.
FDA’s medical device audit framework emphasizes that corrective and preventive actions should be determined, implemented, documented, and evaluated for effectiveness, with actions appropriate to the risk involved.
FDA CAPA Guidance and Current Requirements
When researching FDA CAPA guidance, it is important to distinguish historical FDA guidance from the regulatory framework currently applicable to medical devices.
The former 21 CFR 820.100 provided detailed CAPA requirements for medical device manufacturers, including analyzing quality data, investigating causes, implementing actions, verifying or validating actions where appropriate, documenting actions, and communicating relevant information to management.
The regulatory framework changed when the QMSR became effective on February 2, 2026.
The QMSR incorporates ISO 13485:2016 into 21 CFR Part 820. FDA materials identify ISO 13485 Clauses 8.5.2 and 8.5.3 as covering corrective and preventive action.
FDA also states that corrective and preventive actions should be appropriate to the magnitude of the problem and commensurate with the risks encountered.
Organizations should therefore avoid relying exclusively on older CAPA checklists or references to former 21 CFR 820.100. Their procedures should be reviewed against the current QMSR and other requirements applicable to their products and operations.
What Should an FDA CAPA Process Include?
A robust CAPA workflow can include the following stages.
Each stage should generate appropriate evidence and records.
- Problem Identification: Record the source of the problem and provide a clear description of the issue.
- Risk Assessment: Determine the potential impact and significance of the problem. Risk-based decision making is an important element of the current QMSR framework.
- Root Cause Analysis: Investigate the underlying cause instead of stopping at the immediate symptom.
- Action Planning: Define specific corrective or preventive actions, responsibilities, target dates, and required approvals.
- Implementation: Complete the approved actions and maintain evidence demonstrating implementation.
- Effectiveness Check: Determine whether the implemented action achieved its intended result.
- Closure: Close the CAPA only after required actions and effectiveness activities have been completed and documented.
FDA CAPA Example
Consider a medical device manufacturer that discovers a recurring problem during final inspection: a component is occasionally installed incorrectly.
Step 1: Identify the Problem
Quality inspection data shows that incorrect component installation has occurred repeatedly over several production batches.
The company opens a CAPA because the issue represents a recurring quality problem.
Step 2: Contain the Problem
The company identifies potentially affected products and places them on hold while the issue is investigated.
This immediate containment is different from the longer-term corrective action.
Step 3: Investigate the Root Cause
The investigation examines:
- Work instructions
- Operator training
- Production records
- Equipment
- Component design
- Inspection methods
- Previous nonconformances
- Historical quality data
The investigation determines that the work instruction does not clearly distinguish between two visually similar components.
Step 4: Define Corrective Action
The company may:
- Revise the work instruction
- Add visual identification controls
- Update employee training
- Introduce an additional verification step
- Review whether other products use a similar process
Step 5: Implement the Action
The revised procedure is approved and implemented. Employees receive training, and evidence of training is retained.
Step 6: Verify Effectiveness
The company reviews production and inspection data after implementation.
If the same problem continues, the CAPA investigation may need to be expanded because the original action did not adequately address the underlying cause.
Step 7: Close the CAPA
Once the required actions have been completed and effectiveness has been demonstrated, the CAPA can be reviewed and closed according to the organization’s procedures.
This example illustrates an important principle: a CAPA should address the cause of a quality problem, not simply correct the individual defective product.
CAPA vs. Correction
CAPA and correction are related but different.
A correction addresses an identified problem or nonconforming product.
A corrective action addresses the cause of an existing nonconformity to prevent recurrence.
For example:
Problem: A batch contains products with incorrect labeling.
Correction: Identify and relabel affected products where appropriate.
Corrective action: Investigate why incorrect labels were selected and modify the process or controls to prevent recurrence.
A correction can resolve the immediate issue, while corrective action addresses the underlying system or process problem.
Why CAPA Management Can Become Difficult
Managing CAPA manually using spreadsheets, emails, shared folders, and paper forms can make it difficult to maintain visibility across the entire process.
Common challenges include:
- CAPAs approaching their due dates
- Delayed investigations
- Missing approvals
- Incomplete root-cause analysis
- Scattered supporting evidence
- Difficulty tracking responsibilities
- Repeated quality problems
- Weak visibility into CAPA effectiveness
- Difficulty identifying trends
- Poor connection between complaints, NCRs, audits, and CAPAs
For regulated organizations, maintaining reliable and traceable quality records is particularly important.
CAPA Management Software for FDA Regulated Industries
CAPA management software for FDA regulated industries can provide a centralized environment for managing the CAPA lifecycle.
A QMS platform can help organizations manage:
- CAPA initiation
- CAPA workflows
- Root cause investigations
- Risk assessment
- Corrective and preventive actions
- Action assignments
- Due dates
- Electronic approvals
- Supporting evidence
- Effectiveness checks
- CAPA closure
- Audit trails
- Reporting and analytics
Instead of tracking CAPA activities across multiple spreadsheets and email conversations, quality teams can maintain the information within a controlled workflow.
Connecting CAPA With Other Quality Processes
CAPA is rarely isolated from the rest of a quality management system.
A useful QMS should allow organizations to connect CAPA with processes such as:
Audit → Finding → NCR → CAPA → Root Cause → Corrective Action → Effectiveness Check → Closure
Similarly, customer complaints, supplier issues, inspections, and nonconformances can provide inputs into the CAPA process.
This connected approach can make it easier to identify recurring problems and analyze quality trends.
How QISS QMS Supports CAPA Management
QISS QMS provides a centralized CAPA management workflow designed to help organizations manage corrective and preventive actions more systematically.
Quality teams can use QISS QMS to manage CAPA records, assign responsibilities, track deadlines, document investigations and actions, maintain approvals, and monitor CAPA status.
CAPA can also be connected with other quality processes, including Nonconformance, Audit Management, Customer Complaints, Supplier Management, Risk Management, HSE and Record Management.
For organizations operating in FDA-regulated environments, this type of connected QMS can help provide greater visibility into the lifecycle of quality issues and the actions taken to address them.
Benefits of Digital CAPA Management
A digital CAPA system can help quality teams:
- Improve Traceability: Maintain CAPA information, actions, approvals, and supporting records in one controlled environment.
- Reduce Manual Tracking: Automated workflows and notifications can reduce dependence on spreadsheets and email reminders.
- Improve Accountability: Assign each action to a responsible person with defined deadlines and status tracking.
- Identify Recurring Problems: Connect CAPAs with complaints, audits, NCRs, and other quality data to identify patterns and recurring issues.
- Monitor Effectiveness: Track effectiveness reviews separately from action completion so that closing an action does not automatically mean the CAPA is effective.
- Support Audit Readiness: Maintain organized records that allow quality teams to demonstrate how issues were identified, investigated, addressed, and evaluated.
CAPA Best Practices for FDA-Regulated Organizations
Organizations developing or improving their CAPA process should consider the following practices:
- Define clear CAPA procedures.
- Use risk-based evaluation when determining the appropriate response.
- Investigate root causes rather than treating symptoms.
- Use objective quality data to support investigations.
- Assign clear ownership for every action.
- Set realistic but controlled deadlines.
- Document the evidence supporting each action.
- Evaluate CAPA effectiveness.
- Monitor quality trends for recurring problems.
- Connect CAPA with related quality processes.
- Maintain appropriate records and approvals.
- Review CAPA procedures against current FDA requirements and the QMSR where applicable.
Final Thoughts
CAPA is a core quality-management process for organizations that need to identify, investigate, correct, and prevent quality problems.
For medical device manufacturers, the regulatory landscape changed significantly on February 2, 2026, when the FDA’s QMSR became effective and incorporated ISO 13485:2016 by reference. Corrective and preventive action requirements are now addressed within the QMSR framework through ISO 13485 requirements, including Clauses 8.5.2 and 8.5.3.
Understanding the current FDA CAPA requirements is therefore important for maintaining an effective quality management system.
For organizations managing large numbers of CAPAs, a CAPA management software for FDA regulated industries can help centralize investigations, automate workflows, track actions and deadlines, document effectiveness, and connect CAPA with the broader QMS.
Important: This article is for general educational purposes and does not constitute legal or regulatory advice. FDA requirements can vary depending on the type of product, organization, and applicable regulations. Organizations should review the requirements applicable to their specific products and operations.
